Related Experiment Video
Updated: Jun 28, 2026
Experimental Protocol for Using Drosophila As an Invertebrate Model System for Toxicity Testing in the Laboratory
Published on: July 10, 2018
Drosophila as a model in organophosphate toxicology
Marta Tkachuk1, Nataliya Matiytsiv1
1Department of Genetics and Biotechnology, Ivan Franko National University of Lviv, Lviv, Ukraine.
Abstract:
Organophosphates (OPs) cause acute cholinergic toxicity, oxidative stress, DNA damage, and delayed axonopathy through neuropathy target esterase (NTE) inhibition. Efficient in vivo models capturing this toxicity spectrum are essential for risk assessment and therapeutic discovery. Here, we review Drosophila melanogaster as a versatile platform for OP toxicology across: (1) wild-type assays using dietary and vapour exposures with behavioural endpoints (survival, locomotion, negative geotaxis) and biochemical markers (acetylcholinesterase activity, oxidative stress indices); (2) genotoxicity assessment via the Somatic Mutation and Recombination Test (SMART) and comet assay; and (3) the swiss cheese (sws) mutant model - the Drosophila ortholog of human PNPLA6/NTE - enabling investigation of organophosphate-induced delayed neuropathy (OPIDN) independent of cholinergic effects. Together, these approaches provide hazard characterization and support discovery of protective strategies targeting both cholinergic and non-cholinergic pathways.
Insights
Fruit flies offer a powerful model for studying organophosphate toxicity, assessing both immediate and delayed nerve damage. This research highlights Drosophila
Area of Science:
- Toxicology
- Neuroscience
- Genetics
Background:
- Organophosphates (OPs) induce acute cholinergic toxicity, oxidative stress, DNA damage, and delayed axonopathy via neuropathy target esterase (NTE) inhibition.
- Developing efficient in vivo models is crucial for risk assessment and discovering effective treatments for OP toxicity.
Purpose of the Study:
- To review the utility of Drosophila melanogaster as a versatile platform for comprehensive organophosphate (OP) toxicology studies.
- To explore Drosophila models for assessing OP-induced cholinergic toxicity, genotoxicity, and organophosphate-induced delayed neuropathy (OPIDN).
Main Methods:
- Utilizing wild-type Drosophila for dietary and vapor exposure studies with behavioral and biochemical endpoints.
- Employing the Somatic Mutation and Recombination Test (SMART) and comet assay for genotoxicity assessment.
- Leveraging the swiss cheese (sws) mutant, the Drosophila ortholog of human PNPLA6/NTE, to study OPIDN independently of cholinergic effects.
Main Results:
- Drosophila models effectively capture the spectrum of OP toxicity, including behavioral and biochemical markers of acute toxicity.
- Genotoxicity assays in Drosophila demonstrate potential DNA damaging effects of OPs.
- The sws mutant model successfully investigates OPIDN, revealing pathways distinct from cholinergic toxicity.
Conclusions:
- Drosophila melanogaster provides a robust and versatile in vivo system for comprehensive organophosphate hazard characterization.
- These models facilitate the discovery of protective strategies targeting both the cholinergic and non-cholinergic pathways affected by OPs.
